Salīdzināt metodes
Apskatiet izvēlētās metodes blakus; rindas, kas atšķiras, ir izceltas.
| RMI: Rivermead Mobility Index× | EDSS: Kurtzke paplašinātā invaliditātes skalas× | |
|---|---|---|
| Nozare | Neiroloģija | Neiroloģija |
| Saime | Process / pipeline | Process / pipeline |
| Izcelsmes gads≠ | 1991 | 1983 |
| Autors≠ | Frank Collen, Derick Wade, and Rivermead Rehabilitation Centre | John F. Kurtzke |
| Tips≠ | Clinician-observed performance test | Clinician-rated |
| Pirmavots≠ | Collen, F. M., Wade, D. T., Robb, G. F., Bradshaw, C. M. (1991). The Rivermead Mobility Index: A further development of the Rivermead Motor Assessment. International Disability Studies, 13(2), 50-54. DOI ↗ | Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33(11), 1444-1452. DOI ↗ |
| Citi nosaukumi | Rivermead Mobility Index | Expanded Disability Status Scale |
| Saistītās≠ | 5 | 4 |
| Kopsavilkums≠ | The Rivermead Mobility Index (RMI) is a brief, clinician-observed performance test of basic mobility abilities developed for assessing stroke and neurological rehabilitation outcomes. Published in 1991 by Frank Collen and colleagues at Rivermead Rehabilitation Centre (Oxford, UK), the 15-item index measures bed mobility, sitting/standing balance, transfers, and ambulation. The RMI is widely used in stroke units and rehabilitation settings to track functional recovery and predict discharge outcomes. | The EDSS is the most widely used clinical disability rating scale in multiple sclerosis research and practice. Developed by John Kurtzke in 1983, it provides a 0-10 ordinal scale capturing disease severity across eight neurological functional systems and functional status. The EDSS remains the primary endpoint in MS clinical trials and longitudinal cohort studies, with decades of prognostic and comparative data worldwide. |
| ScholarGateDatu kopa ↗ |
|
|